Evaluate Pharma Alternative

Why do former Evaluate Pharma customers love DealForma?

DealForma specializes in licensing and funding deals as a high-quality, user-friendly, and standalone alternative to Evaluate Pharma.

Comprehensive Coverage

DealForma provides the most extensive coverage of biopharmaceutical transactions, including licensing deals, asset purchases, mergers, acquisitions, research partnerships, and funding rounds, ensuring you have access to a vast repository of relevant data.

In-Depth Analytics

With granular and relevant filters, DealForma allows you to delve into transaction details, track trends, and gain valuable insights into deal structures, valuations, therapeutic areas, and key players, enabling strategic planning, market analysis, and competitive intelligence.

Advanced Deal Monitoring

Business developers are switching to DealForma for its advanced deal monitoring capabilities. The platform enables you to set up alerts for specific criteria, such as target companies, indications, or modalities so you stay informed about the latest developments and deal opportunities.

Finally, a deals database built specifically for biopharma.

DealForma stands out as the best in biopharma deal data with its comprehensive coverage of biotech and pharma licensing and funding transactions by providing a superior experience when it comes to deal terms. We focus on delivering high-quality deal data so you can have confidence that you are getting complete and accurate information for your biopharma business development deal comps and benchmark research.

DealForma Logo
DealForma Logo

Evaluate Pharma

Built for Biopharma

DealForma Logo
Yes

Evaluate Pharma

Yes

Intuitive / Fast Interface

DealForma Logo
Yes

Evaluate Pharma

No

Data Quality / 100% Analyst Checked

DealForma Logo
Yes

Evaluate Pharma

No

Licensing Deals

DealForma Logo
Yes

Evaluate Pharma

No

M&A Deals

DealForma Logo
Yes

Evaluate Pharma

Yes

Contracts and License Agreements

DealForma Logo
Yes

Evaluate Pharma

No

Private Funding Rounds

DealForma Logo
Yes

Evaluate Pharma

Yes

Biopharma License Deal Comps, Upfronts, Options, Milestones, R&D Funding, Royalties, Profit Splits, etc.

DealForma Logo
Yes

Evaluate Pharma

No

Deal Structures and Asset Stages

DealForma Logo
Yes

Evaluate Pharma

No

Deals going back to 2008, Updated Daily

DealForma Logo
Yes

Evaluate Pharma

Yes

Company financials and Investor Profiles

DealForma Logo
Yes

Evaluate Pharma

Yes

Discovery to Clinical Drug Pipelines

DealForma Logo
Yes

Evaluate Pharma

Yes

Biopharma-Specific Filters by Stage, Indication, Modality, Target etc.

DealForma Logo
Yes

Evaluate Pharma

No

Data Visualization / Analytics Dashboards

DealForma Logo

Full Tableau

Evaluate Pharma

No

Source Documents for Every Deal and Funding Record (e.g., Press Releases, SEC-Filed Contracts, Regulatory Docs)

DealForma Logo
Yes

Evaluate Pharma

No

Drug Sales Figures, Quarterly and Regional, with Company Filing Sources

DealForma Logo
Yes

Evaluate Pharma

Yes

Unlimited Data Export to Excel

DealForma Logo

Unlimited

Evaluate Pharma

No

Saved Searches and Alerts

DealForma Logo
Yes

Evaluate Pharma

Yes

VC Analysis

DealForma Logo
No

Evaluate Pharma

Yes

Company-Provided Valuations

DealForma Logo
No

Evaluate Pharma

Yes

Analyst Hours Included

DealForma Logo

20

Evaluate Pharma

No

Minimum Starting Price

DealForma Logo

$18,000

Evaluate Pharma

Not Disclosed

Comparison based on customer feedback and public information gathered June 2023 to the best of our knowledge. We understand the world is constantly changing, so if you see we missed a feature or made a mistake, let us know.

 

DealForma vs. Evaluate Pharma

Evaluate Pharma specializes in consensus forecasts and market research. DealForma focuses specifically on biopharma deals and funding with granular and relevant categories to help with deal comps research and target partner assessment. DealForma offers an intuitive, modern interface with 100% analyst curated profiles, contracts, drug sales figures, and analyst support.

Why are biopharma and finance companies switching to DealForma?

DealForma is a Better Deal Database

We keep hearing from business developers who have tried other databases and DealForma. They are switching to DealForma because of the deal-focused filters and the ability to quickly pull relevant deal comps knowing the content is high-quality. This saves them time when creating reports because the information is verified and up-to-date.

Intuitive, Modern Interface

You know that biopharma business development is full of complex terminology. But you shouldn’t have to remember how a database codes things. DealForma designed its platform from the ground up to make finding the most relevant information fast and easy. DealForma’s granular filters give you the confidence in working with the right data.

Intentional Biopharma Deal Curation

Analysts at DealForma have experience reading thousands of deal and funding announcements and company filings. Teams assigned to each segment look for key terms to separate out from a noisy news flow. And they do this manually, every day, so you can quickly filter through decades of carefully curated, relevant transaction profiles.

Inclusive Analyst Support

DealForma goes beyond a mere database by providing you 20 hours of analyst time per year included with your subscription for you to leverage the expertise of skilled professionals to assist you in data interpretation, perform custom analyses, and provide valuable insights tailored to specific business needs.

DealForma is the most trusted data partner for biopharma deal benchmarks.

Discover why people love DealForma

Want to see how DealForma
can speed up your business development research?

Schedule your personalized 30-minute demo today.

We’ll hop on a screen-sharing call to show you exactly how DealForma can help you find the info you’ve been spending tons of time digging up.